Deals

BioTime Funds Anti-Aging Work with PIPE

By |

BioTime (BTX), a developer of treatments for age-related degenerative diseases, announced that it is raising $5 million in a Common Stock transaction. The common stock was sold at $3.70 per share, an approximate 25% premium to the market price ($2.97) of BTX at deal announcement. A series of 650,000 36-Month Warrants with an exercise price of $5 per share (68.35% premium) was issued to the investor in this transaction. The Placement Agent and the investor were not disclosed. See the PlacementTracker Deal Summary.

Deals

Community Financial Raises Cash with Triple PIPE

By |

Community Financial Shares (CFIS), the Illinois holding company for Community Bank-Wheaton/Glen Ellyn, raised $27 million through a three-way offering of common stock, preferred stock and rights with investors including Clinton Group, Wellington Management Co. and Marlin Capital. The company raised $19.68 million in a Convertible Preferred Stock transaction. The fixed conversion price of the securities is $1.00 per share, an approximate 0.99% discount to the market price ($1.01) of CFIS at deal announcement. The $4 million in common stock was sold at $1.00 per share, an approximate 1% discount to the market price ($1.01) of CFIS at deal announcement. FIG Partners placed the stock transactions, which  are expected to close two days after Shareholder Approval.

Deals

Ultrapetrol Bahamas Raises $220M in Common Stock PIPE

By |

Ultrapetrol Bahamas Ltd. (ULTR) announced that it has raised $220 million in a Common Stock transaction with investor Southern Cross Group. The common stock was sold at $2.00 per share, an approximate 33% premium to the market price ($1.50) of ULTR at deal announcement. The Placement Agent was not disclosed. The transaction is expected to close in December of 2012.

Deals

XenoPort Raises $40M in Dual PIPE

By |

Neurological treatment developer XenoPort (XNPT) announced that it has raised $40 million in a Common Stock transaction at two prices with investor Glaxo Group Ltd. Some $20 million of the common stock was sold at $10.86 per share, an approximate 44% premium to the market price ($7.53) of XNPT at deal announcement. The other $20 million was  sold at $9.13 per share, an approximate 21% premium. The Placement Agent was not disclosed. The transaction closed on Nov. 9, 2012.